本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

ALX Oncology Holdings

0.5135
-0.0265-4.91%
成交量:18.46萬
成交額:9.68萬
市值:2,741.28萬
市盈率:-0.20
高:0.5393
開:0.5282
低:0.5104
收:0.5400
資料載入中...
2024/07/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/17

重要事件披露

Form 8-K - Current report
2024/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/02

重要事件披露

Form 8-K - Current report
2024/04/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/08

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/08

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/07

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/26

重要事件披露

Form 8-K - Current report
2023/12/20

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/14

重要事件披露

Form 8-K - Current report